Tropocells PRP
Commercial- Indications
- Multiple medical applications
Company intelligence / Profile preview
Estar Medical
Holon, Israelestar-medical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Estar Medical’s patented PRP and autologous cell therapy technologies are FDA and CE approved. The company’s products are used globally in multiple medical fields for non-surgical healing treatments. No clinical trial results for drug candidates; the company focuses on device-based regenerative solutions
- Therapeutic areas
- OtherDermatologyOphthalmologyCardiovascular
- Modalities
- Platelet-rich plasma therapyAutologous cell therapyBiologic
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Exclusive U.S. distribution agreement with Aesthetic Management Partners for the Cellenis PRP product line
Beyond the preview
Go deeper on Estar Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Estar Medical.